MAPT and early-onset autosomal dominant Alzheimer disease: This innovative therapeutic strategy achieves comprehensive intervention by concurrently addressing Aβ clearance, Tau pathology, neuroimmune modulation, and mitochondrial restoration, thereby overcoming the constraints of traditional single‐target approaches in Alzheimer's disease.